79 results
8-K
EX-10.1
MDGL
Madrigal Pharmaceuticals, Inc.
27 Jun 24
Departure of Directors or Certain Officers
4:28pm
or the attainment of stated goals or events.
(iv)
Term of Option: Each Option shall terminate not more than ten years from the date of the grant
8-K
EX-99.2
MDGL
Madrigal Pharmaceuticals, Inc.
14 Mar 24
Regulation FD Disclosure
6:47pm
(ME, PA) Reimbursement Goals Established Payer Affordability Fulfillment Engagement Coverage Commercial Decisions (P&T) coverage to ~80% by YE24 Time
S-8
EX-99.1
kytyol ip6mzv455m
11 Sep 23
Registration of securities for employees
4:31pm
8-K
EX-99.1
i3j6q0zm75ndzrk8e1ro
9 May 23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results
8:00am